VA Southern Nevada Healthcare System, North Las Vegas, NV — Las Vegas, Nevada

VA Southern Nevada Healthcare System, North Las Vegas, NV is a clinical research site located in Las Vegas, Nevada, United States 89106.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

VA Southern Nevada Healthcare System, North Las Vegas, NV has participated in 7 clinical trials.

Therapeutic areas: Depressive Disorder, Bipolar Disorder, Suicide.

Sponsors: VA Office of Research and Development.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for VA Southern Nevada Healthcare System, North Las Vegas, NV?

VA Southern Nevada Healthcare System, North Las Vegas, NV has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has VA Southern Nevada Healthcare System, North Las Vegas, NV conducted?

VA Southern Nevada Healthcare System, North Las Vegas, NV has 7 clinical trials on record. Their work covers Depressive Disorder, Bipolar Disorder, Suicide.

Is VA Southern Nevada Healthcare System, North Las Vegas, NV accredited by Crixeo Clinical Trials?

VA Southern Nevada Healthcare System, North Las Vegas, NV has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about VA Southern Nevada Healthcare System, North Las Vegas, NV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.